Alkermes Plc (ALKS)
33.29
-1.62
(-4.64%)
USD |
NASDAQ |
Feb 12, 16:00
33.21
-0.08
(-0.24%)
Pre-Market: 09:26
Alkermes Free Cash Flow : 490.87M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Avadel Pharmaceuticals Plc | 36.80M |
| Krystal Biotech, Inc. | 165.59M |
| Assertio Holdings, Inc. | 13.33M |
| Jazz Pharmaceuticals Plc | 1.282B |
| CorMedix, Inc. | 74.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 101.67M |
| Cash from Investing (Quarterly) | -6.737M |
| Cash from Financing (Quarterly) | 0.315M |
| Free Cash Flow Per Share (Quarterly) | 0.5006 |
| Free Cash Flow to Equity (Quarterly) | 85.44M |
| Free Cash Flow to Firm (Quarterly) | 84.36M |
| Free Cash Flow Yield | 8.77% |